Definium Therapeutics, Inc. DFTX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Definium Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in New York, specializing in the development of psychedelic-derived therapeutics for psychiatric and neurological disorders. Formerly known as MindMed, it focuses on creating scientifically rigorous treatments that target root cause…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees105
TickerDFTX
Statistics
Market Cap$2.54B
Revenue (TTM)$0
Net Income-$183.8M
Net Margin—
EPS$-2.06
P/E-11.70
P/S—
P/B8.67
EV/EBITDA-14.17
ROE-94.7%
Dividend Yield—
Price$24.39
Data: Twelve Data · Revenue = mcap / P/S